Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

NCT00526448 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

384

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: ribavirin
DRUG: ribavirin
DRUG: Peginterferon alfa-2a
DRUG: epoetin beta

Sponsor

Hospital Carlos III, Madrid